• 5 min read
• Published on 25 July 2025
Listen to article
6:18Hey! We are Nemo.
Nemo, short for Never Miss Out, is a mobile investment platform that delivers curated, data-driven investment ideas to your fingertips. It offers commission-free trading across stocks, ETFs, crypto, and CFDs, along with AI-powered tools, real-time market alerts, and themed stock collections called Nemes.
Download the App
Scan the QR code to download the Nemo app and start investing on Nemo today
Published on 12 September 2026
Read article
Published on 12 September 2026
Read article
Published on 12 September 2026
Read article
Published on 11 September 2026
Read article
Published on 11 September 2026
Read article
I’ve seen my fair share of wellness fads. From kale smoothies that taste of righteous misery to mindfulness apps that somehow make me more stressed, the quest for self-improvement is a noisy, and often expensive, business. But lately, something has shifted. The vague promises of ‘wellbeing’ are being replaced by something far more concrete, data-driven, and, to an investor, infinitely more interesting. They call it bio-hacking.
Frankly, the name sounds like something out of a cheap science fiction novel. Yet, the reality is less about rogue scientists in basements and more about a fundamental change in how we approach our own biology. It’s the move from hoping for the best to measuring for the best.
Remember when a fitness tracker was just a glorified pedometer, shaming you for a sedentary Tuesday? Those days are long gone. Today’s wearables are becoming remarkably sophisticated diagnostic tools for the wrist. I’m looking at companies like Zepp Health, which develops the sort of biometric sensors that can offer genuinely useful insights into sleep quality and stress levels. It’s the difference between a blunt instrument and a scalpel.
Then you have firms taking a more focused approach. Movano, with its Evie Ring, is targeting women’s health specifically, a demographic bafflingly overlooked by the tech world for years. It seems an obvious market to me. These devices are no longer just gadgets for tech bros in Silicon Valley. They are becoming mainstream tools for people who want to take proactive control of their health, and that represents a significant commercial opportunity.
Let’s be clear, the shiny bit of kit on your arm is only half the story. The real value, the true engine of this revolution, is the data. Take DexCom, a company that started out making continuous glucose monitors for diabetics. Now, perfectly healthy athletes and executives are wearing them to see in real-time how a croissant affects their metabolism. Why? Because it gives them immediate, actionable information.
This shift from reactive treatment to proactive optimisation could have enormous implications. If you can see the problem coming, you might be able to prevent it. For the healthcare system, that could mean saving a fortune in the long run. For companies like Garmin, which create entire ecosystems of health data, this information becomes an incredibly valuable asset. The more data they gather, the smarter their algorithms become, creating a powerful cycle of improvement.
At the most ambitious end of this trend, we find the world of genetic technology. This is where things get truly transformative. Companies like CRISPR Therapeutics are working on technologies that could, in theory, edit genetic defects at their source. While the immediate focus is on treating severe diseases, one doesn’t need a wild imagination to see the future possibilities for human enhancement.
Of course, this is the highest-stakes part of the industry. It’s fraught with ethical questions and immense regulatory hurdles. The path from a lab to a marketable therapy is long and punishingly expensive. The risks are substantial, but the potential rewards, for both humanity and investors, are equally profound. For those looking to gain exposure to this sprawling and complex theme, a diversified approach might be sensible. A collection of companies like the ones in the Bio-Hacking Revolution basket could offer a way to tap into the trend without betting the farm on a single, high-risk venture.
Investing always carries risk, and this sector is certainly no exception. The path forward for these technologies is not guaranteed. However, with aging populations and a younger generation that is perfectly comfortable trading data for insights, the underlying demand for human optimisation seems unlikely to fade away.
View the full Basket:Bio-Hacking Portfolio
View the full Basket:Bio-Hacking Portfolio
This article is marketing material and should not be construed as investment advice. No information set out in this article be considered, as advice, recommendation, offer, or a solicitation, to buy or sell any financial product, nor is it financial, investment, or trading advice. Any references to specific financial product or investment strategy are for illustrative / educational purposes only and subject to change without notice. It is the investor’s responsibility to evaluate any prospective investment, assess their own financial situation, and seek independent professional advice. Past performance is not indicative of future results. Please refer to our Risk Disclosure.
Published on 12 September 2026
Read article
Published on 12 September 2026
Read article
Published on 12 September 2026
Read article
Published on 11 September 2026
Read article
Published on 11 September 2026
Read article